HOME >> BIOLOGY >> NEWS
Dr. Robert C. Gallo to Collaborate with Visiting Israeli Scientist on Promising HIV Vaccine Research at Marylands Institute of Human Virology

Maryland/Israel Development Center unites leading research communities in Maryland and Israel

BALTIMORE, MD June 1, 2001 The Maryland/Israel Development Center, with the support of Maryland Governor Parris N. Glendening and Israeli Ambassador David Ivry, officially launched today a pioneering program that partners the biotech research communities in the State of Maryland and Israel. At a press briefing held at the Institute of Human Virology (IHV), Hanan Sibel, chairman of the Maryland/Israel Development Center detailed the new program the Maryland/Israel Visiting Fellows Program in Biotechnology which promotes the establishment of long-term research business and investment ties, expand societys knowledge of human diseases such as AIDS and cancer, and encourages the commercialization of products developed as a result of the joint research, thus creating jobs in both Maryland and Israel.

The Maryland/Israel Development Center created the program to help unite Marylands mature biotech community with Israels burgeoning biotech sector for joint research and business activities. According to Sibel, the inaugural grant pairs Israeli scientist Dr. Jonathan Gershoni of Tel-Aviv University with world-renowned virologist Dr. Robert C. Gallo, director of the University of Marylands Institute of Human Virology, a center of the University of Maryland Biotechnology Institute, and co-discoverer of HIV, the virus that causes AIDS. The grant was made official through a proclamation signing between the Governor, Israeli Ambassador Ivry, and the leaders from the University of Maryland Biotechnology Institute, the Institute of Human Virology and the Maryland/Israel Development Center during todays ceremony. Dr. Gershoni and a post-doctoral student from Israel will collaborate with Dr. Gallo and researchers in the basic research division of the IHV, focusing on chemokine-based therapies, a recently discovered approach which have proven effective in pre
'"/>

Contact: Jarrod Walpert
jwalpert@weinbergharris.com
410-427-0123
Maryland/Israel Development Center
31-May-2001


Page: 1 2

Related biology news :

1. Dr. Robert Langer, distinguished leader in the field of biomedical engineering, to lecture at NIH
2. UC Riversides professor Robert Graham elected Fellow of the Soil Science Society of America
3. Robert Horvitz, pioneer in cell death, to be awarded international genetics prize
4. Robert S. Langer to present the 2001 Ullyot Public Affairs Lecture
5. Plant Pathologists Collaborate Worldwide To Combat Sorghum Ergot
6. 26 National Alzheimers Disease Centers Collaborate On Study Of The Utility Of Genetic Testing For Alzheimers
7. Visiting African scientists collaborate with MBL scientists on infectious diseases
8. Touching effects: Visiting plants in the field may alter their future
9. Israeli scientists reveal the plan of a key cellular machine
10. Study by Israeli scientists provides insight on DNA code
11. Scientists identify a gene causing a fatal heart condition, common in an Israeli Bedouin tribe

Post Your Comments:
(Date:5/24/2013)... In the search for medication against Alzheimer,s disease, scientists have ... break down Amyloid beta (A-beta). After all, it is the ... brains of Alzheimer,s patients. Starting point for the formation of ... were the first to unravel the function of APPL ... healthy fruit flies. , Alessia Soldano (VIB/KU Leuven): "We ...
(Date:5/23/2013)... Northwest National Laboratory honored more than 165 staff ... property at PNNL,s annual Intellectual Property Commercialization Recognition ... of Energy national laboratory named materials scientist Jun ... developing battery materials that can store large amounts ... and reduce the time it takes to charge ...
(Date:5/23/2013)... of genomic DNA around nucleosomes in the cell ... team of Ludwig-Maximilians-Universitaet (LMU) in Munich now describes ... locally displaced from nucleosomes for transcription. , In ... the cell nucleus, wrapped around disk-shaped particles called ... different histone proteins and accommodating two loops of ...
Breaking Biology News(10 mins):A new strategy required in the search for Alzheimer's drugs? 2PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2Biochemistry: Unspooling DNA from nucleosomal disks 2
(Date:5/24/2013)... 2013 The Oklahoma tornado left ... ravage, the mayor of Moore, one of the heavily damaged ... a report from cnn.com. Reaching out to also be of ... and Safe Shield to counter the looming mold problem. , ... May 22, 2013, caused 24 deaths, My Cleaning Products shared. ...
(Date:5/23/2013)... 2013 Venaxis, Inc. (Nasdaq:   APPY), an ... FDA clearance and commercializing its rapid, protein biomarker-based appendicitis ... an underwritten public offering of 10,000,000 shares of its ... of its common stock at an exercise price of ... of $1.25 per share and related warrant.  Venaxis has ...
(Date:5/23/2013)... PuraMed BioScience ® , Inc., (OTCBB: ... (OTC) medicinal and healthcare products, announced that Ludlow ... based on low market capitalization valuation. ... Product to Treat Migraine Headaches , Clinical ... , Currently Available Nationwide at Walgreen,s and ...
(Date:5/23/2013)... 23, 2013  Saddleback Memorial Medical Center in ... first hospital on the West Coast to perform a ... option provides women with a state-of-the-art, minimally invasive approach ... Winter , M.D., a highly regarded ... director of minimally invasive surgery at Saddleback Memorial, led ...
Breaking Biology Technology:Mayor of Oklahoma-Tornado-Impaired Town Proposes Storm Shelter Bill, My Cleaning Products Offers Complimentary Molderizer and Safe Shield to Help Victim with Looming Mold 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3
Cached News: